Guest guest Posted November 5, 2005 Report Share Posted November 5, 2005 Hi All, One thing that has me concerned lately is the price of Gleevec for our future. For many of us who have been diagnosed at a fairly " young " age, I worry about our lifetime payout coverages from our private insurance companies. Does anyone have any information or rumor about the price of Gleevec going DOWN? Or, when does the drug patent run out and the generic version come about? I read somewhere that Novartis bought out the largest " generic " company. Does that mean that they will now market and control the monopoly and the price of Gleevec and it's future generic version? I really feel that with the high price of this drug that saves our lives, there must be some type of reduction in the future. Has Novartis broke even with the cost of the initial studies, etc? Is it now all pure profit for them? Will the new competition in CML drugs, like BMS, eventually lower the price of Gleevec? What is going to happen to all of us when our lifetime medical coverages max out? I'm sure it will happen with frequent Dr. visits, every 3 month PCR tests, cbc's, etc.. and biopsy's.. You all know the drill. It must be horrific for all those CML members who do not have any insurance coverage and live in the US. I am very grateful that we have Gleevec, but worry about the price of this drug. The experts now say that CML will probably not be our demise. So, with that being said, what is going to happen in our future and our ability to pay for this lifesaving drug? Sincerely, Lynn (Snickersunny) Dx-d 12/03 PCRU 400 mg Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.